Who can go back to work when the COVID-19 pandemic remits?
Preprint
Abstract
This paper seeks to determine which workers affected by lockdown measures can return to work when a government decides to apply lockdown exit strategies. This system, which we call Sequential Selective Multidimensional Decision (SSMD), involves deciding sequentially, by geographical areas, sectors of activity, age groups and immunity, which workers can return to work at a given time according to the epidemiological criteria of the country as well as that of a group of reference countries, used as a benchmark, that have suffered a lower level of lockdown de-escalation strategies. We apply SSMD to Spain, based on affiliation to the Social Security system prior to the COVID-19 pandemic, and conclude that 98.37% of the population could be affected. The proposed system makes it possible to accurately identify the target population for serological IgG antibody tests in the work field, as well as those affected by special income replacement measures due to lockdown being maintained over a longer period.Keywords
All Related Versions
- Published version: PLOS ONE, 15 (8), e0238299.
This publication has 9 references indexed in Scilit:
- Human mobility restrictions and the spread of the Novel Coronavirus (2019-nCoV) in ChinaJournal of Public Economics, 2020
- The Unprecedented Stock Market Reaction to COVID-19The Review of Asset Pricing Studies, 2020
- Ethical Implementation of Immunity Passports During the COVID-19 PandemicThe Journal of Infectious Diseases, 2020
- Certified Coronavirus Immunity as a Resource and Strategy to Cope with Pandemic CostsKyklos, 2020
- How Two Tests Can Help Contain COVID-19 and Revive the Economy2020
- Labor Markets During the COVID-19 Crisis: A Preliminary View2020
- COVID-19 and Italy: what next?The Lancet, 2020
- Human Mobility Restrictions and the Spread of the Novel Coronavirus (2019-nCoV) in ChinaSSRN Electronic Journal, 2020
- The reproductive number of COVID-19 is higher compared to SARS coronavirusJournal of Travel Medicine, 2020